These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 32197980)

  • 1. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
    Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion Process.
    Perron M; Stray K; Kinkade A; Theodore D; Lee G; Eisenberg E; Sangi M; Gilbert BE; Jordan R; Piedra PA; Toms GL; Mackman R; Cihlar T
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1264-73. PubMed ID: 26666922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Respiratory syncytial virus entry inhibitors targeting the F protein.
    Sun Z; Pan Y; Jiang S; Lu L
    Viruses; 2013 Jan; 5(1):211-25. PubMed ID: 23325327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule inhibits respiratory syncytial virus entry and infection by blocking the interaction of the viral fusion protein with the cell membrane.
    Tang W; Li M; Liu Y; Liang N; Yang Z; Zhao Y; Wu S; Lu S; Li Y; Liu F
    FASEB J; 2019 Mar; 33(3):4287-4299. PubMed ID: 30571312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading.
    Gaillard V; Galloux M; Garcin D; Eléouët JF; Le Goffic R; Larcher T; Rameix-Welti MA; Boukadiri A; Héritier J; Segura JM; Baechler E; Arrell M; Mottet-Osman G; Nyanguile O
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of an allosteric inhibitor class blocking RNA elongation by the respiratory syncytial virus polymerase complex.
    Cox RM; Toots M; Yoon JJ; Sourimant J; Ludeke B; Fearns R; Bourque E; Patti J; Lee E; Vernachio J; Plemper RK
    J Biol Chem; 2018 Oct; 293(43):16761-16777. PubMed ID: 30206124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coptidis Rhizoma extract inhibits replication of respiratory syncytial virus in vitro and in vivo by inducing antiviral state.
    Lee BH; Chathuranga K; Uddin MB; Weeratunga P; Kim MS; Cho WK; Kim HI; Ma JY; Lee JS
    J Microbiol; 2017 Jun; 55(6):488-498. PubMed ID: 28551874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospects For the Use of Peptides against Respiratory Syncytial Virus].
    Shilovskiy IP; Andreev SM; Kozhikhova KV; Nikolskii AA; Khaitov MR
    Mol Biol (Mosk); 2019; 53(4):541-560. PubMed ID: 31397431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor.
    Coates M; Brookes D; Kim YI; Allen H; Fordyce EAF; Meals EA; Colley T; Ciana CL; Parra GF; Sherbukhin V; Stockwell JA; Thomas JC; Hunt SF; Anderson-Dring L; Onions ST; Cass L; Murray PJ; Ito K; Strong P; DeVincenzo JP; Rapeport G
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28652242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory syncytial virus (RSV) entry is inhibited by serine protease inhibitor AEBSF when present during an early stage of infection.
    Van der Gucht W; Leemans A; De Schryver M; Heykers A; Caljon G; Maes L; Cos P; Delputte PL
    Virol J; 2017 Aug; 14(1):157. PubMed ID: 28818113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of residues in the human respiratory syncytial virus fusion protein that modulate fusion activity and pathogenesis.
    Hotard AL; Lee S; Currier MG; Crowe JE; Sakamoto K; Newcomb DC; Peebles RS; Plemper RK; Moore ML
    J Virol; 2015 Jan; 89(1):512-22. PubMed ID: 25339762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus entry and how to block it.
    Battles MB; McLellan JS
    Nat Rev Microbiol; 2019 Apr; 17(4):233-245. PubMed ID: 30723301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late therapeutic intervention with a respiratory syncytial virus L-protein polymerase inhibitor, PC786, on respiratory syncytial virus infection in human airway epithelium.
    Brookes DW; Coates M; Allen H; Daly L; Constant S; Huang S; Hows M; Davis A; Cass L; Ayrton J; Knowles I; Strong P; Rapeport G; Ito K
    Br J Pharmacol; 2018 Jun; 175(12):2520-2534. PubMed ID: 29579332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin from Scutellaria baicalensis blocks respiratory syncytial virus (RSV) infection and reduces inflammatory cell infiltration and lung injury in mice.
    Shi H; Ren K; Lv B; Zhang W; Zhao Y; Tan RX; Li E
    Sci Rep; 2016 Oct; 6():35851. PubMed ID: 27767097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aesculus hippocastanum L. seed extract shows virucidal and antiviral activities against respiratory syncytial virus (RSV) and reduces lung inflammation in vivo.
    Salinas FM; Vázquez L; Gentilini MV; O Donohoe A; Regueira E; Nabaes Jodar MS; Viegas M; Michelini FM; Hermida G; Alché LE; Bueno CA
    Antiviral Res; 2019 Apr; 164():1-11. PubMed ID: 30711418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures.
    Broadbent L; Parke HG; Ferguson LJ; Millar A; Shields MD; Detalle L; Power UF
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.